E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/29/2005 in the Prospect News Biotech Daily.

Kendle upgraded by Jefferies to buy

Kendle International Inc. was upgraded by Jefferies & Co. analyst David Windley to a buy rating from hold and raised the price target on the stock to $21 per share from $13 following second-quarter results. Kendle shares Friday climbed $1.45, or 8.58%, to close at $18.35 on volume of 229,122 shares versus the three-month running average of 86,445.3 shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.